Annals of Surgical Oncology Cite Track
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

10.1245/s10434-007-9625-z
Annals of Surgical Oncology 15:227-232 (2008)
© 2008 Society of Surgical Oncology
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Park, I. J.
Right arrow Articles by Kim, J. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Park, I. J.
Right arrow Articles by Kim, J. C.

Original Article

Radiofrequency Ablation for Metachronous Liver Metastasis from Colorectal Cancer after Curative Surgery

In Ja Park, MD1, Hee Cheol Kim, MD1, Chang Sik Yu, MD1, Pyo Nyun Kim, MD2, Hyung Jin Won, MD2 and Jin Cheon Kim, MD1

1 Department of Surgery, University of Ulsan College of Medicine, and Colorectal Cancer Team, Asan Cancer Center, 388-1 Poongnap-dong, Songpa-gu, Seoul 138-736, Korea
2 Department of Radiology, University of Ulsan College of Medicine, and Colorectal Cancer Team, Asan Cancer Center, 88-1 Poongnap-dong, Songpa-gu, Seoul 138-736, Korea

Correspondence: Address correspondence and reprint requests to: Hee Cheol Kim, MD; E-mail: hckim{at}amc.seoul.kr

Background: We compared outcomes of surgery and radiofrequency thermal ablation (RFA) in patients with metachronous liver metastases.

Methods: Between October 1995 and December 2005, 59 patients underwent hepatic resection and 30 underwent RFA for metachronous liver metastases. Patients with extrahepatic metastases, those who underwent both types of treatment, and those with synchronous hepatic metastasis were excluded.

Results: The two groups had similar mean age, sex ratio, comorbid medical conditions, primary disease stage, and frequency of solitary metastases. Preoperative mean serum carcinoembryonic antigen (CEA) level was significantly higher in the RFA group (13.4 ng/mL vs. 7.7 ng/mL; p = 0.02). Mean diameter of hepatic metastases was significantly greater in the resection than in the RFA group (3.1 cm vs. 2.0 cm; p = 0.001). Recurrence after treatment of metastasis was observed in 18 of 30 (60.0%) RFA and 33 of 59 (56%) resection patients. Local recurrence at the RFA site was observed in 7 of 30 (23%) patients. Time to recurrence (15 vs. 8 months, p = 0.02) and overall survival (56 vs. 36 months, p = 0.005) were significantly longer in the resection than in the RFA group. In the 69 patients with solitary metastases of diameter ≤3 cm, time to recurrence (p = 0.004) and overall survival were significantly greater in the resection group.

Conclusions: Compared with hepatic resection, RFA for metachronous hepatic metastases from colorectal cancer was associated with higher local recurrence and shorter recurrence-free and overall survival rates, even in patients with solitary, small (≤3 cm) lesions.

Key Words: Colorectal cancer • Liver metastasis • RFA • Resection







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2008 by the Society of Surgical Oncology.